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Abstract: Previous findings on the capacity of Hibiscus sabdariffa (HS) polyphenols to 
ameliorate metabolic disturbances justify the necessity of studies oriented to find the 
potential metabolites responsible for such an effect. The present study examined the 
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intestinal epithelial membrane permeability of polyphenols present in a phenolic-enriched  
Hibiscus sabdariffa extract (PEHS), free and encapsulated, using the Caco-2 cell line. 
Additionally, selected polyphenols (quercetin, quercetin-3-glucoside, quercetin-3-glucuronide, 
and N-feruloyltyramine) were also studied in the same absorption model. The powerful 
analytical platform used ultra-high-performance liquid chromatography coupled with 
ultra-high-resolution quadrupole time-of-flight mass spectrometry (UHPLC-ESI-UHR-Qq-
TOF-MS), and enabled the characterization of seven new compounds in PEHS. In the 
permeation study, only a few compounds were able to cross the cell monolayer and the 
permeability was lower when the extract was in an encapsulated form. Pure compounds 
showed a moderate absorption in all cases. Nevertheless, these preliminary results may need 
further research to understand the complete absorption mechanism of Hibiscus polyphenols. 




Hibiscus sabdariffa L. (HS) (family Malvaceae), commonly named bissap, roselle, red sorrel,  
or karkade, is a tropical plant commonly used as a beverage in folk medicine for the treatment of diverse 
disorders such as constipation, heart ailments, high blood pressure, urinary tract infections, cancer, diabetes, 
or hepatic disorders [1–4]. Recent studies have focused on its antioxidant [5,6], antimicrobial [7,8],  
anti-inflammatory [9,10], anti-adipogenic [11], immunomodulatory [10], hepatoprotective [12,13], 
anticancer [14,15], cardioprotective [16–18], or diuretic activities [19]. Proteins, lipids, carbohydrates, 
minerals, and vitamins, as well as less polar compounds such as sterols, are present in its composition [20]. 
HS possesses organic and phenolic acids such as citric, hibiscus, or protocatechuic acids; flavonoids 
such as quercetin, luteolin, and their glycosides; and anthocyanins such as cyanidin-3-O-sambubioside, 
cyanidin-3-O-glucoside, or delphinidin-3-O-sambubioside, which are responsible for the bright red color 
of their calyces [11,21,22]. 
We have previously reported the capability of HS polyphenols to modulate triglyceride accumulation, 
oxidative stress, and inflammation in insulin-resistant adipocytes at relatively low doses, i.e., 10–40 μg/mL 
(phenolic-enriched Hibiscus sabdariffa (PEHS) extract) and with large doses in human volunteers 
(10 g of an aqueous extract) [11,23], and to prevent fatty liver disease in a hyperlipidemic mouse model 
through miRNA-mediated glucose and lipid homeostasis regulation. We have accumulated enough 
evidence to propose that some flavonols may be the major contributors to the observed effects [17,24]. 
Nevertheless, a synergistic interaction among several components in the extract and a multi-targeted 
mechanism has been proposed [11,25]. Recent human studies in patients suffering metabolic syndrome 
support the potential therapeutic use of the extract derived from HS calyces against hypertension when 
administered at a dose of 125 mg/kg/day for four weeks [26]. In this scenario, the study of the absorption 
and bioavailability of the major compounds and the identification of the putative metabolites is needed 
to elucidate their molecular targets and for the complete understanding of their mechanism. 
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In the present study, the permeability of major polyphenols present in a PEHS, both free and 
encapsulated, has been studied for the first time using the Caco-2 human colon cell line as a model of 
human intestinal absorption. Additionally, the absorption of selected glycosylated and non-glycosylated 
polyphenols or metabolites related to the extract was also studied in the same model. 
2. Results and Discussion 
2.1. Characterization of the Phenolic-Enriched Hibiscus sabdariffa (PEHS) Extract 
The first step in the present study was to perform a complete characterization of the PEHS extract 
using an optimized analytical methodology. Thus, UHPLC-ESI-UHR-Qq-TOF-MS was used for the 
detection and characterization of phenolic and other polar compounds present in the extract. The base 
peak chromatogram obtained for this extract showed the presence of 32 compounds (Figure 1). These 
compounds were tentatively identified using the information provided by the UHR-Qq-TOF-MS, 
comparing their mass spectra and elution order with standards when available, and after a thorough 
survey of the literature. Data concerning the information of the detected compounds are summarized in 
Table 1, which lists the peak number, retention time, experimental m/z, calculated m/z, error (ppm) and 
sigma values, generated molecular formula, and proposed compound. Intraday and interday precisions 
were developed in order to assess the robustness of the method. A sample of the PEHS extract was 
injected three times in the same day (intraday precision, n = 3) and three times for three consecutive 
days (interday precision, n = 9). The intraday repeatability of peak area, expressed as the relative standard 
deviation (RSD) (%), was between the interval of 0.13%–2.87%, whereas the interday repeatability was 
between 0.37%–3.29%. 
 
Figure 1. Base peak chromatogram of PEHS extract; peaks are identified with numbers 
according to the elution order. 
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Table 1. List of the compounds detected in phenolic-enriched Hibiscus sabdariffa (PEHS) 














1 3.4 207.0146 207.0146 −0.0 C6H8O8 Hydroxycitric acid 
2 3.6 189.0041 189.0041 −0.1 C6H6O7 Hibiscus acid 
3 4.3 235.0458 235.0459 0.4 C8H12O8 Hibiscus acid hydroxyethylesther 
4 4.5 595.1303 595.1305 0.3 C26H28O16 Delphinidin-3-sambubioside 
5 4.8 315.0720 315.0722 0.4 C13H16O9 Chlorogenic acid quinone 
6 5.3 353.0874 353.0878 1.0 C16H18O9 Neochlorogenic acid 
7 5.5 579.1350 579.1355 0.9 C26H28O15 Cyanidin-3-sambubioside 
8 6.0 217.0352 217.0354 1.0 C8H10O7 Hibiscus acid dimethylesther 
9 6.3 353.0877 353.0878 0.3 C16H18O9 Chlorogenic acid 
10 6.7 353.0877 353.0878 0.3 C16H18O9 Cryptochlorogenic acid 
11 7.1 335.0408 335.0409 0.1 C15H12O9 Methyl digallate 
12 7.9 369.0460 369.0463 0.8 C15H14O11 2-O-trans-caffeoyl-hydroxicitric acid 
13 8.2 353.0874 353.0878 1.0 C16H18O9 1-O-caffeoylquinic acid 
14 8.5 611.1246 611.1254 1.3 C26H28O17 Myricetin-3-arabinogalactoside 
15 9.0 337.0925 337.0929 1.3 C16H18O8 Coumaroylquinic acid 
16 9.2 236.0563 236.0564 0.6 C11H11NO5 UK 
17 9.7 263.0772 263.0772 0.0 C10H16O8 
Hibiscus acid 
hydroxyethyldimethylesther 
18 10.7 595.1305 595.1305 −0.0 C26H28O16 Quercetin-3-sambubioside 
19 11.3 335.0771 335.0772 0.4 C16H16O8 5-O-caffeoylshikimic acid 
20 12.0 263.0773 263.0772 −0.3 C10H16O8 2-O-trans-feruloyl-hydroxicitric acid 
21 12.3 609.1458 609.1461 0.5 C27H30O16 Quercetin-3-rutinoside 
22 13.1 385.1139 385.1140 0.3 C17H22O10 UK 
23 13.6 579.1356 579.1355 −0.2 C26H28O15 Kaempferol-3-O-sambubioside 
24 14.0 463.0882 463.0882 0.0 C21H20O12 Quercetin-3-glucoside 
25 15.3 593.1512 593.1512 −0.0 C27H30O15 Kaempferol-3-O-rutinoside 
26 15.5 381.1190 381.1191 0.1 C18H22O9 Ethylchlorogenate 
27 17.1 319.0826 319.0823 −0.8 C16H16O7 Methylepigallocatechin 
28 17.7 457.1716 457.1715 −0.1 C21H30O11 UK 
29 20.3 317.0309 317.0303 −1.8 C15H10O8 Myricetin 
30 24.5 312.1245 312.1241 −1.2 C18H19NO4 N-feruloyltyramine 
31 26.4 301.0358 301.0354 −1.4 C15H10O7 Quercetin 
32 29.1 285.0415 285.0404 −3.6 C15H10O6 Kaempferol 
Most of the identified compounds have been previously described in PEHS extract [11,22]. 
Nevertheless, seven new compounds were identified due to the use of UHR-Qq-TOF-MS, a detector  
with a high resolution and extreme sensitivity. Thus, peaks 3 and 26, proposed as hibiscus acid 
hydroxyethylesther and ethylchlorogenate, respectively, were detected in the previous analysis of the 
PEHS extract but it was impossible to confirm their identity with the available information. Furthermore, 
chlorogenic acid quinone, 1-O-caffeoylquinic acid, hibiscus acid hydroxyethyldimethylesther,  
2-O-transferuloylhydroxicitric acid, and kaempferol, corresponding to peaks 5, 13, 17, 20 and 32, 
respectively, have been detected for the first time in the PEHS extract. 
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Moreover, other phenolic and polar compounds were identified in the extract, corresponding to 
different families. It should be pointed out that there was a presence of a wide variety of organic acids 
and derivatives, such as hydroxycitric and hibiscus acids, 2-O-trans-caffeoylhydroxycitric acid, hibiscus 
acid dimethylesther, hibiscus acid hydroxyethylesther, hibiscus acid hydroxyethyldimethylesther,  
5-O-caffeoylshikimic acid, and coumaroylquinic acid. Several phenolic acids and derivatives were 
detected in the extract, such as chlorogenic acid, its isomers neo and cryptochlorogenic acids and 
derivatives such as chlorogenic acid quinone or ethylchlorogenate, as well as methyldigallate. 
Furthermore, other flavonoids and their glycosidic derivatives were characterized in the extract.  
The presence of the following should be highlighted: quercetin and its glucoside, rutinoside,  
and sambubioside conjugates; kaempferol and its rutinoside and sambubioside forms; myricetin, 
myricetin-3-arabinogalactoside, and methylepigallocatechin. Additionally, anthocyanins responsible for 
the bright red color calyces of HS, specifically delphinidin-3-sambubioside and cyanidin-3-sambubioside, 
were also detected, as well as the compound N-feruloyltyramine. 
Despite the efforts made in order to characterize the extract, Table 1 shows three compounds named  
as unknown (UK in Table 1) for which it was impossible to elucidate a structure due to lack of sufficient 
evidence. The table includes retention time, experimental m/z, molecular formulas, errors, and σ values. 
The use of a powerful analytical technique such as UHPLC-ESI-UHR-Qq-TOF-MS has been  
a valuable tool, allowing the characterization of seven new compounds for the first time in this plant 
matrix. These new compounds were in their majority organic and phenolic acid derivatives, such as 
hibiscus acid hydroxyethylesther, ethyl chlorogenate, chlorogenic acid quinone, 1-O-caffeoylquinic acid, 
hibiscus acid hydroxyethyldimethylesther, and 2-O-trans-feruloyl-hydroxycitric acid. Furthermore, 
kaempferol was also detected in this extract for the first time. The compound ethyl chlorogenate has 
been found in various extracts of different plants with hepatoprotective and antiviral activities [27,28]. 
On the other hand, chlorogenic acid quinone is an oxidative product of chlorogenic acid by polyphenol 
oxidase, one of the major polyphenols present in plants [29,30]. The compound 1-O-caffeoylquinic acid 
has been found in different plants and foods, such as potato, tomato, or artichoke, among others [31–33]; 
also, the compound 2-O-trans-feruloyl-hydroxycitric acid is found in corn [34]. Moreover, kaempferol 
has been previously found in the petals of this plant matrix as well as in rat plasma after the oral 
administration of the PEHS extract [17,35]. 
2.2. Permeability of Free and Encapsulated PEHS Extracts 
One of the aims of this study was to compare the intestinal absorption of HS compounds when the 
PEHS extract was in a free form or in an encapsulated formulation, using the Caco-2 model system. This 
model is a well-established in vitro model for the investigation of the intestinal permeability of different 
compounds or drugs [36,37]. Prior to the transport studies, the Caco-2 cell monolayer was established 
and validated. Monolayer integrity and reliability were ensured by measuring the transepithelial 
electrical resistance (TEER) values, which remained stable during the assay with the experimental 
conditions assayed. Afterwards, samples from apical and basolateral compartments obtained at different 
time points and cytoplasmic and membrane fractions of the cell monolayer collected at the end of the 
assay (see Sections 3.3 and 3.4) were analyzed by UHPLC-ESI-UHR-Qq-TOF-MS in order to identify 
which compounds crossed the Caco-2 cell monolayer. The results are summarized in the Table 2. 
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Table 2. Compounds detected in the transport medium, cytoplasm, and membrane obtained in apical to basolateral (Ap-Bas) and basolateral to 
apical (Bas-Ap) transport directions in the Caco-2 assay with the free and encapsulated PEHS. The symbol + indicated that the compound  
was detected. 
Extract Free PEHS Encapsulated PEHS 
Compound 
Transport Medium Cytoplasm Membrane Transport Medium Cytoplasm Membrane 
Ap-Bas  
 
Bas-Ap Ap-Bas Bas-Ap Ap-Bas Bas-Ap  
 
Ap-Bas Bas-Ap Ap-Bas Bas-Ap Ap-Bas Bas-Ap  
 
Hibiscus acid         +    
Neochlorogenic acid + +     + + +    
Hibiscus acid 
dimethylesther 
        +  + + 
Chlorogenic acid + +      + +    
Cryptochlorogenic acid + +     + + + +   
Methyldigallate  +      + +    
Coumaroylquinic acid  +          + 
5-O-caffeoylshikimic acid + +      +     
Methylepigallocatechin  +           
N-feruloyltyramine + +     + +     
Quercetin + + +  +    +    
Ap-Bas: Apical-Basolateral flux; Bas-Ap: Basolateral-Apical flux; +: Presence of the compound in the sample. 
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Thus, for the free PEHS extract, the analysis of the transport medium revealed the presence of chlorogenic 
acid, cryptochlorogenic acid, neochlorogenic acid, 5-O-caffeoylshikimic acid, N-feruloyltyramine, and 
quercetin in the receiver chamber in both flux directions. Additionally, the compounds methyldigallate, 
coumaroylquinic acid, and methylepigallocatechin were also detected only in the basolateral-apical flux. 
Although the high polarity of the main compounds in PEHS suggested that encapsulation in 
liposomes would increase the permeability of these compounds, a lower permeability was observed 
when encapsulated PEHS was used. The number and amount of compounds transported across  
the membrane decreased compared to free PEHS extract. Thus, in the apical-basolateral flux study,  
the compounds detected in the transport medium of the receiver chamber were neochlorogenic and 
cryptochlorogenic acids and N-feruloyltyramine. On the contrary, more compounds were detected in  
the acceptor compartment for the basolateral-apical flow, such as chlorogenic acid and its isomers, 
methyldigallate, 5-O-caffeoylshikimic acid, and N-feruloyltyramine (Table 2). 
These results showed the potential of the very sensible analytical instrumentation used, which allowed 
the detection of several compounds in the acceptor chambers in both flux directions and with the two 
PEHS assayed formulations. 
The uptake of the compounds present in both formulations of PEHS by the Caco-2 cells was also 
monitored by analyzing the cytoplasmic content of the cell monolayer collected at the end of the assay. 
Quercetin was found in the cytoplasm of the Caco-2 cells when the permeation of the free extract  
was monitored in the apical-basolateral direction. On the other hand, in the case of the encapsulated 
form, cryptochlorogenic acid was the only compound detected in the cytoplasm of the cells in the 
basolateral-apical flux, while in the opposite direction, seven compounds were detected: hibiscus acid, 
hibiscus acid dimethylesther, chlorogenic acid and its isomers, methyldigallate, and quercetin. 
Phenolic compounds have shown a significant capacity to bind phospholipid membranes [38–40] and 
this fact may account for most of their membrane-related effects [41]; therefore, the possible presence 
of the phenolic compounds from PEHS in the cell membrane fraction was also explored. Caco-2 cell 
membranes were collected at the end of the assay, treated as explained in the Sections 3.3 and 3.4,  
and subsequently analyzed by UHPLC-ESI-UHR-Qq-TOF-MS. The results showed that only 
quercetin was detected to be associated with membranes in the apical-basolateral flow study for the 
free PEHS extract. On the other hand, for the encapsulated PEHS extract, hibiscus acid dimethylesther 
and coumaroylquinic acid were detected in the membrane fraction, although the last compound was only 
found in the basolateral-apical direction. 
The fact that only a few compounds were able to pass across the gut barrier model in both permeation 
studies could be partly due to the complex composition of the extract. The presence of high 
concentrations of several polyphenols in the extract could lead to a saturation of the specific transport 
mechanisms of the phenolic compounds through the cell monolayer or to the loss of sink conditions.  
The results obtained here reveal valuable information in order to identify the putative metabolites that 
would reach the target tissues and would account for the effects of HS extract. 
2.3. Permeation of Pure Compounds Related to PEHS Composition 
Although the study of the absorption of a complex extract resembles the in vivo processes better,  
the interference among the different compounds and the saturation of membrane transporters makes it 
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difficult to quantitate the absorption of the different compounds. To avoid this situation, we studied  
the absorption process of a selection of pure polyphenols related to PEHS, previously identified as 
metabolites in an animal model (quercetin, quercetin-3-glucoside, quercetin-3-glucuronide, and  
N-feruloyltyramine). Three different forms of the flavonol quercetin, i.e., its aglycone, the glycosylated 
and the glucuronidated forms, were used in the absorption cell model, since the amount of quercetin 
derivatives found in PEHS was fairly abundant [11] and quercetin metabolites were detected in  
several mouse tissues [24] and plasma samples of rats [17] after the oral consumption of PEHS.  
N-feruloyltyramine was also studied since this compound was fairly abundant in PEHS extract and 
appeared as a metabolite in animal studies [17,24]. Neither phenolic acids nor anthocyanins were 
selected for absorption studies since phenolic acids have been thoroughly studied in the bibliography 
and anthocyanins are poorly absorbed [42–46]. 
Quercetin and N-feruloyltyramine showed significant absorption in the experiments performed with 
the whole extract, so their individual permeation study was of interest to understand their absorption  
in model conditions. There is a certain controversy in respect to the permeability of quercetin and  
its derivatives. Whereas the permeability of quercetin-glucoside conjugates was higher than that 
observed for the aglycone [47,48], the opposite conclusion was made in other assays [49]. Therefore,  
the glycosylated and aglycone forms were compared in the absorption cell model. On the other hand, 
quercetin-glucuronide conjugates have been postulated as major metabolites derived from the phase II 
metabolism of quercetin aglycone or different glycoside derivatives [50]. On some occasions,  
the metabolites generated inside the enterocytes could be transported again to the intestinal lumen by  
the ABC transporters. 
Standard calibration curves of the compounds under study were prepared using apigenin at  
a concentration of 10 μg/mL as an internal standard. All calibration curves showed good linearity within 
different concentration ranges depending on the analytes studied. The limits of detection (LODs) and 
limits of quantification (LOQs) for individual compounds in standard solutions were also calculated as 
S/N = 3 and S/N = 10, respectively, where S/N is the signal to noise ratio (Table 3). The compound 
concentrations were subsequently determined using the corrected area of each individual compound 
(three replicates) and by interpolation in the corresponding calibration curve. Repeatability of the 
proposed method was measured as the relative standard deviation (RSD, %) in terms of concentration. 
A mixed solution containing the analytes was injected several times (n = 3) on the same day (intraday 
precision) and three times on three consecutive days (interday precision, n = 9). Intraday repeatability 
of the method developed for all the analytes was from 0.11% to 1.93%, whereas the interday repeatability 
ranged from 0.17% to 2.06%. The contents of the monitored compounds in the receiver chambers at 
different times are shown in Table 4. 
In some cases, the analysis of the samples by UHPLC-ESI-UHR-Qq-TOF-MS collected at different 
times in the receptor compartment revealed that the compounds of interest were not detected.  
This happened in the samples collected after 30, 60 and 90 min for quercetin-3-glucuronide in  
the apical-basolateral flux. In other cases, the presence of these compounds was detected but could not 
be quantified since the contents were below the LOQs. Moreover, the presence of these compounds was 
not found in the analysis of the cytoplasm and membrane fractions collected at the end of the assay. 
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Quercetin 0.05 0.17 0.17–20 y = 13.372 x − 0.0038 0.998
Quercetin-3-glucoside 0.07 0.23 0.23–55 y = 2.5235 x + 0.0113 0.988
Quercetin-3-glucuronide 0.03 0.11 0.2–45 y = 11.545 x + 0.0087 0.992
N-feruloyltyramine 0.014 0.048 0.2–40 y = 14.995 x + 0.1088 0.990
Table 4. Concentration (μg/mL) of compounds from the receptor chamber in the individual 
permeability assays. Value = X ± SD. ND: non-detected, <LOQ: below the LOQ. 
Apical-Basolateral Flux 
Time (min) 30 60 90 120 
Quercetin 0.28 ± 0.02 0.49 ± 0.03 1.33 ± 0.02 1.32 ± 0.01 
Quercetin-3-glucoside <LOQ <LOQ <LOQ 0.47 ± 0.03 
Quercetin-3-glucuronide ND ND ND <LOQ 
N-feruloyltyramine 0.69 ± 0.02 2.3 ± 0.2 4.2 ± 0.5 6.6 ± 0.8 
Basolateral-Apical Flux 
Time (min) 30 30 30 30 
Quercetin 1.1 ± 0.4 1.1 ± 0.4 1.1 ± 0.4 1.1 ± 0.4 
Quercetin-3-glucoside <LOQ <LOQ <LOQ <LOQ 
Quercetin-3-glucuronide <LOQ <LOQ <LOQ <LOQ 
N-feruloyltyramine 1.35 ± 0.04 1.35 ± 0.04 1.35 ± 0.04 1.35 ± 0.04 
It is important to remark that the concentration found for all the compounds in the basolateral-apical 
direction was higher than that found in the flux of the other direction. Furthermore, the permeation of 
quercetin-3-glucoside and quercetin-3-glucuronide in the apical-basolateral direction occurred to such a 
lesser extent that these compounds could not be quantified for several time-points. 
The maximum permeation of quercetin was reached after 90 min of the assay for both flux directions, 
but the final concentration in the basolateral-apical flux was around five-fold higher than the opposite 
flux (see Table 4). For the other assayed compounds, the maximum concentration was found in the 
samples collected at the end of the assay (120 min). These findings revealed a faster and more effective 
absorption of quercetin compared to their derivatives, which may justify the fact that the aglycone 
reaches its molecular targets in a more effective way [49]. 
In conclusion, our results suggest the existence of significant absorption across the intestinal  
barrier of some of HS polyphenols, most probably by passive diffusion, especially for quercetin and  
N-feruloyltyramine (compounds detected when the free and encapsulated PEHS extracts were assayed). 
With respect to N-feruloyltyramine, as far as we are concerned, this study represents the first report 
for the permeation study of this compound in the in vitro Caco-2 cell model. On the contrary,  
the results showed that the absorption of the glycosylated flavonols, i.e., quercetin-3-glucoside and 
quercetin-3-glucuronide, occurred in to a lesser extent. Moreover, the higher permeability in the 
basolateral-apical direction found for all the assayed compounds suggests a secretion transport 
mechanism to the intestinal lumen, which produces a decrease in the net absorption of these compounds. 
Our results are also in agreement with those reporting a higher absorption of quercetin compared to its 
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different glycosylated forms [49], and compared to those showing a higher permeability in the 
basolateral-apical direction [49,51]. 
3. Experimental Section 
3.1. Chemicals and Reagents 
All chemicals were of analytical HPLC grade and used as received. Ethanol, acetonitrile,  
soy phosphatidylcholine, formic acid, and trifluoroacetic acid were purchased from Sigma-Aldrich  
(St. Louis, MO, USA). The resin used for the preparative chromatography was AmberliteTM  
FPX66 (Rohm and Haas, Philadelphia, PA, USA). Standard compounds quercetin (purity ≥ 98%), 
quercetin-3-glucoside (purity ≥ 98%), and quercetin-3-glucuronide (purity ≥ 95%) were supplied by  
Sigma-Aldrich and N-feruloyltyramine (purity ≥ 95%) by Chem–Faces (Wuhan, China). Lastly, Hank’s 
Balance culture medium (HBSS) was obtained from Gibco (Life Technologies, Gaithersburg, MD, USA) 
and methanol and DMSO, used for the preparation of the stock solutions, were purchased from Fisher 
Scientific (Pittsburgh, PA, USA). 
3.2. Preparation of PEHS 
Primary aqueous extract was obtained from sun-dried calyces from plants harvested in Senegal, with 
an approximate plant-to-extract ratio of 5:1 as previously described [23]. The purified PEHS extract  
was kindly provided by Monteloeder, Inc. (Elche, Alicante, Spain) and was essentially prepared as 
previously described [11]. The retained phenolic fraction was finally eluted with 95% ethanol and  
0.01% trifluoroacetic acid (TFA), rotatory evaporated and freeze-dried. The PEHS encapsulated 
formulation was performed using empty liposomes, whose final concentration was 2 mM, adding soy 
phosphatidylcholine to the blend. To permeabilize the liposome membrane ethanol 10% was used.  
The extract was dissolved in HBSS at the desired concentration (2500 μg/mL), stirred for 10 min, and 
finally filtered through 0.45 μm three times (PVD filter).  
3.3. Cell Culture and Permeability Studies 
To assess the potential intestinal absorption of PEHS and pure compounds, experiments were 
conducted using Caco-2 cells derived from human colorectal adenocarcinoma cells (obtained from the 
American Type Culture Collection). Cells were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM) containing 10% (v/v) fetal bovine serum (FBS) and incubated at 37 °C in a humidified 5% 
CO2 air atmosphere. Cell monolayers were prepared by seeding 5 × 105 Caco-2cells/well on a six-well 
Transwell insert filter. Monolayers were used 19–22 days after seeding. The integrity of each cell 
monolayer was checked by measuring its transepithelial electrical resistance (TEER) with an epithelial 
voltohmmeter (EVOM, World Precision Instrument, Sarasota, FL, USA) before and after the experiments. 
The culture medium was replaced with fresh medium 24 h before the transport experiments. Compounds 
were added after washing the Caco-2 cell monolayer twice with pre-warmed HBSS medium (pH 7.4),  
in the apical or in the basolateral side, to evaluate the transport characteristics of the cells. Permeability 
studies were done by adding the PEHS solution at a concentration of 2500 μg/mL, quercetin at  
18.1 μg/mL, quercetin-3-glucoside at 46.4 μg/mL, quercetin-3-glucuronide at 47.8 μg/mL, and  
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N-feruloyltyramine at 31.3 μg/mL, while the receiving chamber contained the corresponding volume of 
transport medium. Samples were taken at different times (30, 60, 90, 120 min) and stored at −80 °C until 
their treatment. 
After the permeation study, the Caco-2 cell monolayer was collected and the cells were lysed with  
three subsequent freezing-thawing cycles followed by bath sonication, of 10 min each step. Then,  
the samples were centrifuged during 15 min at 14,000 rpm and 4 °C, and the supernatants (cytoplasmic 
fraction) and the pellets (membranes) were stored at −80 °C. 
3.4. Sample Treatments 
For the UHPLC-ESI-UHR-Qq-TOF-MS analysis of the free PEHS, the extract was dissolved in 
ultrapure water up to a concentration of 2500 ppm, stirring in a vortex and filtered with single-use filter 
units of cellulose acetate (0.45 μm) prior to the injection into the HPLC system. 
The samples collected in the receiving chamber during the permeability assays were centrifuged for 
15 min at 12,000 rpm and 4 °C. The supernatant was spiked with apigenin stock solution, used as an 
internal standard at a concentration of 10 μg/mL, in order to avoid irreproducibility of results between 
analyses. Finally, the samples were stored at −80 °C until the analysis, avoiding possible degradations. 
The cytoplasms and cell membranes collected at the end of the permeability assays were subjected to 
protein precipitation using methanol, vortex-mixed, kept at −20 °C for 2 h and centrifuged at 12,000 rpm 
for 15 min at 4 °C. Finally, the supernatants were evaporated in a vacuum concentrator, dissolved in 100 μL 
of methanol, and then spiked with 10 μg/mL of apigenin, used as an internal standard for their analysis. 
3.5. Analytical Methodology 
For the analysis of the samples, a Dionex Ultimate 3000 UHPLC (Thermo Scientific, Sunnyvale, CA, 
USA) was used coupled with an ultra-high resolution quadrupole time-of-flight mass spectrometer 
maXis (UHR-Qq-TOF-MS) from Bruker Daltonik (Bremen, Germany). The chromatographic separation 
was performed in a Zorbax Eclipse Plus C-18 column (4.6 × 150 mm, 1.8 μm) at a flow rate of  
0.3 mL/min using an injection volume of 5 μL. The mobile phases consisted in water-acetonitrile (90:10, 
v/v) with 0.5% of formic acid as eluent A and acetonitrile as eluent B. The following multi-step linear 
gradient was applied: 0 min, 5% B; 10 min, 35% B; 32 min 75% B; 37 min, 5% B; finally, the initial 
conditions were held for three minutes to equilibrate the system before the subsequent injection. 
The UHPLC system was directly coupled to a UHR-Qq-TOF mass spectrometer via an electrospray 
ionization interface (ESI) operating in negative ionization mode using a capillary voltage of +4.5 kV. 
The optimum parameters for the ionization source were: drying gas flow, 8 L/min; drying gas 
temperature, 200 °C; nebulizer gas pressure, 2 bar. The other optimum values for UHR-Qq-TOF-MS 
parameters were: funnel RF, 300.0 Vpp; collision RF, 400 Vpp; transfer time, 65 μs; pre-pulse storage, 
6 μs; ion cooler, 40 Vpp. 
For all the experiments the detection was carried out considering a mass range of 50–1100 m/z,  
and using nitrogen as nebulizing and drying gas. The instrument was calibrated externally with a  
74900-00-05 Cole Palmer syringe pump (Vernon Hills, IL, USA) directly connected to the interface and 
containing a 10 mM sodium formate cluster solution. The calibration solution was prepared as follows: 
10 μL of 1 M sodium hydroxide was mixed with 990 μL of 0.1% formic acid in water:isopropanol  
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(1:1, v/v). The mixture was injected at the beginning of each run (Figure 1 calibration segment) and all 
the spectra were calibrated prior to compound characterization. Due to the compensation of temperature 
drifts in the instrument, this external calibration provided accurate mass values of better than 5 ppm.  
The accurate mass data of the molecular ions were processed using Data Analysis 4.0 software  
(Bruker Daltonik), which provides a list of possible elemental formulas via the Generate Molecular 
Formula Editor. 
4. Conclusions 
The use of a powerful analytical technique such as UHPLC-ESI-UHR-Qq-TOF-MS has been  
a valuable tool to carry out the absorption study of the phenolic compounds from a PEHS extract in an 
in vitro model for intestinal absorption. The proposed method allowed the characterization of seven new 
compounds for the first time in this plant matrix. These new compounds were in their majority organic 
and phenolic acid derivatives. In the permeability study of PEHS, only a few compounds were able to 
cross the cell monolayer in both flux directions. In addition, the results highlighted a lower permeation 
of the compounds from the encapsulated formulation of PEHS compared to the free formulation. 
Furthermore, four individual compounds related to PEHS extract were studied in the same absorption 
model (quercetin, quercetin-3-glucoside, quercetin-3-glucuronide, and N-feruloyltyramine), and  
the results indicated a significant absorption in the gut barrier model for all the compounds. On the other 
hand, all the assays showed a higher basolateral-apical permeability, suggesting the existence of  
a transport efflux mechanism of these compounds. 
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